VERTEX PHARMACEUTICALS INC / MA (VRTX) /
The debt of VERTEX PHARMACEUTICALS INC / MA over the past 10 years
Chart VERTEX PHARMACEUTICALS INC / MA: liquid cash, total debt, net cash, fiscal 2016–2025 Open the chart →At the end of fiscal 2025, the latest fiscal year on file, VERTEX PHARMACEUTICALS INC / MA had liquid cash of $6.61B and total debt of $0: net cash of $6.61B. It had more liquid cash than debt at all 9 year-ends shown. Total debt was highest at the end of fiscal 2016 ($300M) and lowest at the end of fiscal 2018 ($0). No net cash figure is on file for fiscal 2017.
Year by year
| Fiscal year | Liquid cash | Total debt* | Net cash* |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $6.61B* | $0 | $6.61B |
| 2024ended Dec 31, 2024 | $6.12B* | $0 | $6.12B |
| 2023ended Dec 31, 2023 | $11.22B* | $0 | $11.22B |
| 2022ended Dec 31, 2022 | $10.78B* | $0 | $10.78B |
| 2021ended Dec 31, 2021 | $7.52B* | $0 | $7.52B |
| 2020ended Dec 31, 2020 | $6.66B* | $0 | $6.66B |
| 2019ended Dec 31, 2019 | $3.81B* | $0 | $3.81B |
| 2018ended Dec 31, 2018 | $3.17B* | $0 | $3.17B |
| 2017ended Dec 31, 2017 | $2.09B* | — | — |
| 2016ended Dec 31, 2016 | $1.43B* | $300M | $1.13B |
Fiscal years as VERTEX PHARMACEUTICALS INC / MA reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on VERTEX PHARMACEUTICALS INC / MA
- The revenue of VERTEX PHARMACEUTICALS INC / MA
- The profitability of VERTEX PHARMACEUTICALS INC / MA
- The cash flow of VERTEX PHARMACEUTICALS INC / MA
- All of VERTEX PHARMACEUTICALS INC / MA's financials, charted
Companies of a similar size
- SPGIS&P Global Inc.
- PGRPROGRESSIVE CORP/OH/
- UBERUber Technologies, Inc
- FTNTFORTINET, INC.
- LMTLOCKHEED MARTIN CORPORATION
Not investment advice. This page shows what VERTEX PHARMACEUTICALS INC / MA filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.